Retraction:
Retraction: In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway
Metrics: PDF 92 views | ?
1Department of Breast, Linyi Cancer Hospital, Linyi 276000, P.R. China
2Department of Pathology, Linyi Cancer Hospital, Linyi 276000, P.R. China
3Operating Theatre, Daqing Oilfield General Hospital, Daqing 163000, P.R. China
Published: August 14, 2024
Copyright: © 2024 Kong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been retracted: In Figure 7C, the second and sixth panels contain images duplicated from Figure 7 of [1]. This same figure also contains a partially duplicated panel from Figure 7C of a second paper, which has been retracted [2]. The journal requested clarification regarding these images from the authors. The authors have acknowledged that some images provided by a third-party lab may be unreliable, and thus the data is compromised. In light of these facts, the Editorial decision was made to retract this paper. All authors agreed with the decision. Linyi cancer hospital acknowledged the retraction of this paper.
REFERENCES
1. Wu F, Li J, Guo N, Wang XH, Liao YQ. MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling pathway. Am J Cancer Res. 2017; 7:405–16. [PubMed].
2. Mao XW, Xiao JQ, Xu G, Li ZY, Wu HF, Li Y, Zheng YC, Zhang N. CUL4B promotes bladder cancer metastasis and induces epithelial-to-mesenchymal transition by activating the Wnt/β-catenin signaling pathway. Oncotarget. 2017; 8:77241–53. https://doi.org/10.18632/oncotarget.20455. [PubMed]. Retraction in: Oncotarget. 2024; 15:542–542. https://doi.org/10.18632/oncotarget.28407. [PubMed].
Original article: Oncotarget. 2017; 8:15507–15519. DOI: https://doi.org/10.18632/oncotarget.14662
![Creative Commons License](/images/80x15.png)
PII: 28616